A rise in the prevalence of prostate cancer and neuroendocrine tumors, and a surge in the use of nuclear imaging techniques propel the gallium-68 market growth. However, the short half-life of gallium-68 impede the market growth. The use of radioactive tracers in cancer diagnosis is expected to bring new trends in the gallium-68 market in […]